Literature DB >> 33803298

Structure and Distribution of Health Care Costs across Age Groups of Patients with Multimorbidity in Lithuania.

Laura Nedzinskienė1, Elena Jurevičienė1,2, Žydrūnė Visockienė1,2, Agnė Ulytė3, Roma Puronaitė1,2,4, Vytautas Kasiulevičius1,2, Edita Kazėnaitė1,2, Greta Burneikaitė1,2, Rokas Navickas1,2.   

Abstract

BACKGROUND: Patients with multimorbidity account for ever-increasing healthcare resource usage and are often summarised as big spenders. Comprehensive analysis of health care resource usage in different age groups in patients with at least two non-communicable diseases is still scarce, limiting the quality of health care management decisions, which are often backed by limited, small-scale database analysis. The health care system in Lithuania is based on mandatory social health insurance and is covered by the National Health Insurance Fund. Based on a national Health Insurance database. The study aimed to explore the distribution, change, and interrelationships of health care costs across the age groups of patients with multimorbidity, suggesting different priorities at different age groups.
METHOD: The study identified all adults with at least one chronic disease when any health care services were used over a three-year period between 2012 and 2014. Further data analysis excluded patients with single chronic conditions and further analysed patients with multimorbidity, accounting for increasing resource usage. The costs of primary, outpatient health care services; hospitalizations; reimbursed and paid out-of-pocket medications were analysed in eight age groups starting at 18 and up to 85 years and over.
RESULTS: The study identified a total of 428,430 adults in Lithuania with at least two different chronic diseases from the 32 chronic disease list. Out of the total expenditure within the group, 51.54% of the expenses were consumed for inpatient treatment, 30.90% for reimbursed medications. Across different age groups of patients with multimorbidity in Lithuania, 60% of the total cost is attributed to the age group of 65-84 years. The share in the total spending was the highest in the 75-84 years age group amounting to 29.53% of the overall expenditure, with an increase in hospitalization and a decrease in outpatient services. A decrease in health care expenses per capita in patients with multimorbidity after 85 years of age was observed.
CONCLUSIONS: The highest proportion of health care expenses in patients with multimorbidity relates to hospitalization and reimbursed medications, increasing with age, but varies through different services. The study identifies the need to personalise the care of patients with multimorbidity in the primary-outpatient setting, aiming to reduce hospitalizations with proactive disease management.

Entities:  

Keywords:  Lithuania; care costs; patients with multimorbidity

Year:  2021        PMID: 33803298      PMCID: PMC7967257          DOI: 10.3390/ijerph18052767

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  28 in total

1.  Prescription drug spending for Medicare+Choice beneficiaries in the last year of life.

Authors:  Cheryl Fahlman; Joanne Lynn; Danielle Doberman; Jon Gabel; Mike Finch
Journal:  J Palliat Med       Date:  2006-08       Impact factor: 2.947

2.  A survey of primary care physicians in eleven countries, 2009: perspectives on care, costs, and experiences.

Authors:  Cathy Schoen; Robin Osborn; Michelle M Doty; David Squires; Jordon Peugh; Sandra Applebaum
Journal:  Health Aff (Millwood)       Date:  2009-11-02       Impact factor: 6.301

3.  Costs associated with multimorbidity among VA patients.

Authors:  Jean Yoon; Donna Zulman; Jennifer Y Scott; Matthew L Maciejewski
Journal:  Med Care       Date:  2014-03       Impact factor: 2.983

4.  The burden of disease in older people and implications for health policy and practice.

Authors:  Martin J Prince; Fan Wu; Yanfei Guo; Luis M Gutierrez Robledo; Martin O'Donnell; Richard Sullivan; Salim Yusuf
Journal:  Lancet       Date:  2014-11-06       Impact factor: 79.321

5.  Income-, education- and gender-related inequalities in out-of-pocket health-care payments for 65+ patients - a systematic review.

Authors:  Sandro Corrieri; Dirk Heider; Herbert Matschinger; Thomas Lehnert; Elke Raum; Hans-Helmut König
Journal:  Int J Equity Health       Date:  2010-08-11

6.  Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden.

Authors:  Alessandra Marengoni; Bengt Winblad; Anita Karp; Laura Fratiglioni
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

7.  The challenge of measuring multi-morbidity and its costs.

Authors:  Raphael Wittenberg
Journal:  Isr J Health Policy Res       Date:  2015-01-26

Review 8.  Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies.

Authors:  Concepció Violan; Quintí Foguet-Boreu; Gemma Flores-Mateo; Chris Salisbury; Jeanet Blom; Michael Freitag; Liam Glynn; Christiane Muth; Jose M Valderas
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

9.  Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults.

Authors:  Daniel Polsky; Machaon Bonafede; Jose A Suaya
Journal:  BMC Health Serv Res       Date:  2012-10-31       Impact factor: 2.655

10.  Multimorbidity and comorbidity of chronic diseases among the senior Australians: prevalence and patterns.

Authors:  M Mofizul Islam; Jose M Valderas; Laurann Yen; Paresh Dawda; Tanisha Jowsey; Ian S McRae
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

View more
  2 in total

1.  Analysis of Healthcare Expenditures in Bulgaria.

Authors:  Zornitsa Mitkova; Miglena Doneva; Nikolay Gerasimov; Konstantin Tachkov; Maria Dimitrova; Maria Kamusheva; Guenka Petrova
Journal:  Healthcare (Basel)       Date:  2022-01-30

2.  Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) Comorbidities in Lithuanian National Database: A Cluster Analysis.

Authors:  Elena Jurevičienė; Greta Burneikaitė; Laimis Dambrauskas; Vytautas Kasiulevičius; Edita Kazėnaitė; Rokas Navickas; Roma Puronaitė; Giedrė Smailytė; Žydrūnė Visockienė; Edvardas Danila
Journal:  Int J Environ Res Public Health       Date:  2022-01-15       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.